American Journal of Medicine and Medical Sciences
p-ISSN: 2165-901X e-ISSN: 2165-9036
2025; 15(4): 1212-1216
doi:10.5923/j.ajmms.20251504.75
Received: Mar. 26, 2025; Accepted: Apr. 19, 2025; Published: Apr. 26, 2025
Yuldasheva Khurziyo Fakhiddinovna 1, Khayredinova Ilnara Ilgizovna 2
1Head of the Compulsory Treatment Department at the Tashkent Regional Branch of the Republican Specialized Scientific-Practical Medical Center for Mental Health, Narcology Service, Tashkent, Uzbekistan
2PhD., Senior Lecturer at the Department of Psychiatry and Narcology, Tashkent Medical Academy, Head of the Department of Narcology and Toxicology at the Republican Specialized Scientific-Practical Medical Center for Mental Health, Tashkent, Uzbekistan
Correspondence to: Yuldasheva Khurziyo Fakhiddinovna , Head of the Compulsory Treatment Department at the Tashkent Regional Branch of the Republican Specialized Scientific-Practical Medical Center for Mental Health, Narcology Service, Tashkent, Uzbekistan.
Email: | ![]() |
Copyright © 2025 Scientific & Academic Publishing. All Rights Reserved.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Relevance. In recent years, there has been an increase in the use of synthetic cathinones, which are a group of novel psychoactive substances. One of the most significant consequences of their use is the development of psychotic disorders; however, the relationship between synthetic cathinones and psychosis remains insufficiently studied. Objective. To conduct a systematic literature review aimed at identifying and summarizing data on the impact of synthetic cathinone use on the development of psychoses, as well as to clarify the features of this association and the possible mechanisms involved. Methods. A literature search was conducted in the PubMed and Google Scholar databases (2013–2024), including studies containing information on psychotic symptoms in patients who used synthetic cathinones. The analysis included works describing clinical cases with confirmed use of synthetic cathinones and the development of psychotic disorders. Articles without specific data on the substances used or psychiatric symptoms were excluded. Results. The final sample included 15 studies analyzing 29 cases of psychosis induced by synthetic cathinone use. The most common symptoms were hallucinations (41%) and delusional disorders (28%). Nearly half of the patients (48%) exhibited psychomotor agitation and aggression. Psychosis was registered in men in 86% of the cases, with a median age of 29 years. Psychosis most frequently developed after the use of MDPV, α-PVP, and mephedrone. Discussion. The findings confirm that synthetic cathinones have a high potential to induce psychoses, causing acute hallucinatory-delusional disorders with a high incidence of aggression and suicidal behavior. Cathinone-induced psychoses resemble amphetamine and cocaine psychoses in their clinical presentation but are often accompanied by more pronounced emotional disturbances. Polysubstance abuse and pre-existing psychiatric disorders are identified as risk factors increasing the likelihood of psychotic episodes. Conclusions. The use of synthetic cathinones is associated with the risk of both acute and chronic psychosis. While compounds in this group share similar activity, they differ in symptom severity. The findings highlight the need for early diagnosis, preventive measures, and further research into the mechanisms underlying cathinone-induced psychosis.
Keywords: Synthetic cathinones, Psychosis, Hallucinations, Delusions, Polysubstance abuse, Mental disorders, Psychostimulants
Cite this paper: Yuldasheva Khurziyo Fakhiddinovna , Khayredinova Ilnara Ilgizovna , Psychoses Induced by Synthetic Cathinone Use, American Journal of Medicine and Medical Sciences, Vol. 15 No. 4, 2025, pp. 1212-1216. doi: 10.5923/j.ajmms.20251504.75.